IDEANOMICS INC (IDEX)

US45166V2051 - Common Stock

0.9  -0.02 (-2.17%)

Fundamental Rating

1

IDEX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. IDEX may be in some trouble as it scores bad on both profitability and health. IDEX is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

IDEX had negative earnings in the past year.
In the past year IDEX has reported a negative cash flow from operations.
IDEX had negative earnings in each of the past 5 years.
IDEX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

IDEX has a Return On Assets of -224.62%. This is amonst the worse of the industry: IDEX underperforms 97.67% of its industry peers.
IDEX's Return On Equity of -1393.74% is on the low side compared to the rest of the industry. IDEX is outperformed by 94.57% of its industry peers.
Industry RankSector Rank
ROA -224.62%
ROE -1393.74%
ROIC N/A
ROA(3y)-67.81%
ROA(5y)-62.03%
ROE(3y)-102%
ROE(5y)-129.85%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IDEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IDEX has been increased compared to 1 year ago.
The number of shares outstanding for IDEX has been increased compared to 5 years ago.
Compared to 1 year ago, IDEX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -12.75, we must say that IDEX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -12.75, IDEX is doing worse than 93.02% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that IDEX is not too dependend on debt financing.
The Debt to Equity ratio of IDEX (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -12.75
ROIC/WACCN/A
WACC6.28%

2.3 Liquidity

A Current Ratio of 0.42 indicates that IDEX may have some problems paying its short term obligations.
IDEX has a Current ratio of 0.42. This is amonst the worse of the industry: IDEX underperforms 97.67% of its industry peers.
IDEX has a Quick Ratio of 0.42. This is a bad value and indicates that IDEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IDEX (0.27) is worse than 96.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.27

4

3. Growth

3.1 Past

The earnings per share for IDEX have decreased strongly by -158.65% in the last year.
IDEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.01%.
The Revenue has been decreasing by -6.92% on average over the past years.
EPS 1Y (TTM)-158.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q42.46%
Revenue 1Y (TTM)-49.01%
Revenue growth 3Y31.28%
Revenue growth 5Y-6.92%
Revenue growth Q2Q-97.26%

3.2 Future

Based on estimates for the next years, IDEX will show a very strong growth in Earnings Per Share. The EPS will grow by 41.37% on average per year.
The Revenue is expected to grow by 128.25% on average over the next years. This is a very strong growth
EPS Next Y99.62%
EPS Next 2Y41.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year198.73%
Revenue Next 2Y128.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IDEX. In the last year negative earnings were reported.
Also next year IDEX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as IDEX's earnings are expected to grow with 41.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IDEX!.
Industry RankSector Rank
Dividend Yield N/A

IDEANOMICS INC

NASDAQ:IDEX (4/29/2024, 2:58:52 PM)

0.9

-0.02 (-2.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.80M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -224.62%
ROE -1393.74%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.42
Quick Ratio 0.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-158.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y99.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-49.01%
Revenue growth 3Y31.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y